Showing results (591-600 of 942) with videos related to
Sort By:
Pageof 95
Neurology and Therapy|March 13, 2026
Early Cenobamate as a Third-Line Option in Drug-Resistant Focal Epilepsy: A Paradigm Shift?Fedele Dono, Mirella Russo, Rita Agosto, et al.Neurology and Therapy|March 12, 2026
Ultra-Long-Term Real-World Outcomes of Lower Extremity Nerve Decompression for Painful Diabetic Peripheral Neuropathy: A Retrospective Cohort StudyChenlong Liao, Shuo Li, Wenxiang Zhong, et al.Neurology and Therapy|November 1, 2023
Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGERichard B Lipton, Janette Contreras-De Lama, Daniel Serrano, et al.Neurology and Therapy|December 5, 2016
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational StudySimona Malucchi, Marco Capobianco, Marianna Lo Re, et al.Neurology and Therapy|October 17, 2016
The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple SclerosisSheena L Dupuy, Shahamat Tauhid, Shelley Hurwitz, et al.Neurology and Therapy|November 12, 2018
Patient and Physician Perspectives in a Case of Severe Traumatic Brain InjuryRhoderick M CasisNeurology and Therapy|March 29, 2019
Targeting Higher Levels of Tau Protein in Ukrainian Patients with Wilson's DiseaseYevgeniya Lekomtseva, Ivan Voloshyn-Gaponov, Gorbach TataynaNeurology and Therapy|July 18, 2019
Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?Victor M RiveraNeurology and Therapy|February 18, 2017
Comparative Effectiveness Research of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of a Large Health Insurance Claims DatabaseAaron Boster, Jacqueline Nicholas, Ning Wu, et al.Neurology and Therapy|March 23, 2019
Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software PlatformsDorothy Keine, Mark Zelek, John Q Walker, et al.Pageof 95